Latest
industry research report on: Global Estrogen Replacement Therapy
(ERT) Market | Industry Size, Share, Research, Reviews, Analysis,
Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
The estrogen replacement
therapy (ERT) is witnessing significant rise in demand and hence
growth of the market globally. This rising demand for estrogen
replacement therapy is mainly attributed to increasing awareness
about menopausal symptoms and its treatment opportunities. Another
key factor responsible for the growth of this market is growing
population of the post-menopausal women requiring ERT worldwide.
Due to change in hormonal
levels in the body, women suffer from various debilitating symptoms.
ERT is one of the hormone replacement therapies that includes
replenishment of estrogen hormone levels in women through
administration of external estrogen and/or progesterone hormones.
Estrogen replacement therapy helps in treating women suffering from
menopausal symptoms. It decreases the symptoms like vaginal dryness,
hot flashes, disturbed sleep, night sweats, etc. ERT helps in
osteoporosis prevention caused due to depletion of estrogen levels in
the body. ERT comprises of natural as well as synthetic estrogen
hormones. In order to enhance the menopausal treatment, it is also
given in combination with progesterone hormone.
Complete Report Details @
https://www.marketresearchreports.biz/reports/1357566/estrogen-replacement-therapy-ert-market-research-reports
The
ERT market has recorded positive growth in the recent past due to
growing demand for the therapy worldwide. Due to the substantial
growth in demand for ERT there has been introduction of highly safe
treatment options for the patients located in different geographies
of the world. For instance, development of novel drug delivery
systems (NDDSs) like vaginal estrogen drugs and transdermal estrogen
patches. Another form of ERT such as Low dose ERT are utilized in
order to address the backdrop caused due to safety concerns raised
against high-dose forms. The non-hormonal treatment have proven least
effective, hence the ERT market is expected to grow at a rapid pace
during the forecast period.
The
key restraining factor for the ERT market could be the cost of this
therapy. The monthly treatment cost for ERT varies from US$ 40 to US$
150. Therefore, the population from developing and underdeveloped
countries face the challenge of affordability for the therapy.
Approved recognition of the products related to ERT in compounding
pharmacies particularly from developed countries is another deterring
factor. The post treatment risk of cervical cancer and coronary
disease can also prove to be the restraining factors for the growth
of this market.
GlobalERT
market can be segmented based on dosage forms, routes of
administration, end-users and geography. Based on dosage forms, the
ERT market can be segmented into patches, tablets, gels/creams,
suppositories, implants and injections. The tablet dosage form
segment dominated the globalERT market in 2015. However, due to
growing safety concerns and demand for effective long-term therapy,
the market for injections, gels/creams and patches is expected to
witness high growth during the forecast period. Based on routes of
administration, the ERT market can be classified into oral, topical,
subcutaneous pellets, injections, etc. Oral route of administration
has remained the most preferred option for the patients’ world
over. However, novel drug delivery systems such as topical and
subcutaneous products have also witnessed increased demand and
acceptance in the global market in the recent past.
Geographically,
North America especially the U.S. occupied the largest market share
followed by other developed regions such as Western Europe and Japan.
The U.S. have been the major market for ERT across the world due to
high awareness levels and implausible purchasing power of the people
in the country that further led to the expansion of ERT market in the
country. However, the same factor of affordability has restrained the
market in the developing regions of the world. Despite this, the
emerging economies of the Asia Pacific region have displayed striking
increase in the growth rates in the ERT market segment. Rising
population, increasing disposable income, and improving health care
awareness levels are some the key factors driving the Asia Pacific
ERT market.
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiryBuy/1357566
Some of the key players
operating in the ERT market include AbbVie, Inc., Bayer AG, Hisamitsu
Pharmaceutical Co., Inc., Novartis AG, Novo Nordisk A/S, Orion Pharma
AB, Pfizer, Inc., Meda pharmaceuticals, Teva Pharmaceutical
Industries Ltd. and TherapeuticsMD, Inc. among others.
The report offers a
comprehensive evaluation of the market. It does so via in-depth
insights, understanding market evolution by tracking historical
developments, and analyzing the present scenario and future
projections based on optimistic and likely scenarios. Each research
report serves as a repository of analysis and information for every
facet of the market, including but not limited to: Regional markets,
technology developments, types, applications, and the competitive
landscape.
The study is a source of
reliable data on:
Key market segments and
sub-segments
Evolving market trends and
dynamics
Changing supply and demand
scenarios
Quantifying market
opportunities through market sizing and market forecasting
Tracking current
trends/opportunities/challenges
Competitive insights
Opportunity mapping in
terms of technological breakthroughs
The regional analysis
covers:
North America (U.S. and
Canada)
Latin America (Mexico,
Brazil, Peru, Chile, and others)
Western Europe (Germany,
U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands,
Luxembourg)
Eastern Europe (Poland,
Russia)
Asia Pacific (China, India,
Japan, ASEAN, Australia and New Zealand)
Middle East and Africa
(GCC, Southern Africa, North Africa)
TMR estimates the market size
of various sectors using a combination of available data on the
number and revenue of companies within each sub-sector and tiers of
companies. The basic components used to determine market size and
forecast for a specific product area are not only limited to
supply-side data, but are also related to demand, industry trends,
and the economic outlook. All the above data points are utilized to
generate a statistical model targeting the sector marketplace. More
than 300 TMR analysts across the world integrate these elements into
a framework to determine the subsector market size for a base year
and then forecast growth within each market.
TMR regularly interviews
technology and business professionals as an ongoing effort to track
the latest developments within each sector. These continuous surveys
are stratified by company size and industry segment and weighted to
reflect the global market place. All data are collected on an
ongoing effort through a structured questionnaire rolled over the web
or conducted via telephones. This provides the TMR team opportunities
to request for detailed question sets, complex skip patterns, and
real-time calculations, which assists respondents in answering
questions involving numbers and percentages. Respondents, who are
interviewed as experts, are screened and qualified based on certain
criteria in addition to their decision-making authority and the scope
of activity within their organizations.
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment